163 related articles for article (PubMed ID: 36350309)
1. Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.
Black K; Brenn BR; Gaedigk A; Wanderer JP; Van Driest SL
Clin Transl Sci; 2023 Feb; 16(2):269-278. PubMed ID: 36350309
[TBL] [Abstract][Full Text] [Related]
2. CYP2D6 basic genotyping as a potential tool to improve the antiemetic efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting.
Niewiński PA; Wojciechowski R; Śliwiński M; Hurkacz ME; Głowacka K; Orzechowska-Juzwenko K; Wiela-Hojeńska AK
Adv Clin Exp Med; 2018 Nov; 27(11):1499-1503. PubMed ID: 30058787
[TBL] [Abstract][Full Text] [Related]
3. Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.
Edwards A; Teusink-Cross A; Martin LJ; Prows CA; Mehta PA; Ramsey LB
Clin Transl Sci; 2022 Mar; 15(3):610-618. PubMed ID: 34670017
[TBL] [Abstract][Full Text] [Related]
4. The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?
Candiotti KA; Birnbach DJ; Lubarsky DA; Nhuch F; Kamat A; Koch WH; Nikoloff M; Wu L; Andrews D
Anesthesiology; 2005 Mar; 102(3):543-9. PubMed ID: 15731591
[TBL] [Abstract][Full Text] [Related]
5. The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.
Wesmiller SW; Henker RA; Sereika SM; Donovan HS; Meng L; Gruen GS; Tarkin IS; Conley YP
Biol Res Nurs; 2013 Oct; 15(4):382-9. PubMed ID: 22718526
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of Postoperative Nausea and Vomiting.
Aroke EN; Hicks TL
J Perianesth Nurs; 2019 Dec; 34(6):1088-1105. PubMed ID: 31227296
[TBL] [Abstract][Full Text] [Related]
7. CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Jallaq SA; Verba M; Strawn JR; Martin LJ; DelBello MP; Ramsey LB
J Child Adolesc Psychopharmacol; 2021 Feb; 31(1):56-62. PubMed ID: 32845723
[No Abstract] [Full Text] [Related]
8. Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis.
Liao Y; Sun Y; Guo J; Kang Z; Sun Y; Zhang Y; He J; Huang C; Sun X; Zhang JM; Wang J; Wang HN; Chen ZY; Wang K; Pan J; Ni AH; Weng S; Wang A; Cao C; Sun L; Zhang Y; Kuang L; Zhang Y; Liu Z; Yue W;
EBioMedicine; 2024 Jun; 104():105165. PubMed ID: 38776596
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of 5HT3-receptor antagonists in postoperative nausea and vomiting: the role of pharmacogenetics.
Theodosopoulou P; Rekatsina M; Staikou C
Minerva Anestesiol; 2023 Jun; 89(6):565-576. PubMed ID: 36852569
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 genotype and adverse events to risperidone in children and adolescents.
Oshikoya KA; Neely KM; Carroll RJ; Aka IT; Maxwell-Horn AC; Roden DM; Van Driest SL
Pediatr Res; 2019 Apr; 85(5):602-606. PubMed ID: 30661084
[TBL] [Abstract][Full Text] [Related]
11. Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status.
Tveito M; Molden E; Høiseth G; Correll CU; Smith RL
Eur J Clin Pharmacol; 2020 Jan; 76(1):41-49. PubMed ID: 31637453
[TBL] [Abstract][Full Text] [Related]
12. Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial.
Campos GO; de Jesus Martins M; Jesus GN; de Oliveira PRR; Lessa CN; de Oliveira Junior JCMF; de Castro Alves LJS; Alves RL; Módolo NSP
BMC Anesthesiol; 2019 Aug; 19(1):159. PubMed ID: 31421679
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 predicted metabolizer status and safety in adult patients with attention-deficit hyperactivity disorder participating in a large placebo-controlled atomoxetine maintenance of response clinical trial.
Fijal BA; Guo Y; Li SG; Ahl J; Goto T; Tanaka Y; Nisenbaum LK; Upadhyaya HP
J Clin Pharmacol; 2015 Oct; 55(10):1167-74. PubMed ID: 25919121
[TBL] [Abstract][Full Text] [Related]
14. Effects of ondansetron in the prevention of postoperative nausea and vomiting in children.
Ummenhofer W; Frei FJ; Urwyler A; Kern C; Drewe J
Anesthesiology; 1994 Oct; 81(4):804-10. PubMed ID: 7943830
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
16. High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population.
Pietarinen P; Tornio A; Niemi M
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):291-6. PubMed ID: 27038154
[TBL] [Abstract][Full Text] [Related]
17. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.
Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH
Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics.
Rossow KM; Oshikoya KA; Aka IT; Maxwell-Horn AC; Roden DM; Van Driest SL
J Dev Behav Pediatr; 2021 Apr; 42(3):205-212. PubMed ID: 33759847
[TBL] [Abstract][Full Text] [Related]
19. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes.
Kaiser R; Sezer O; Papies A; Bauer S; Schelenz C; Tremblay PB; Possinger K; Roots I; Brockmöller J
J Clin Oncol; 2002 Jun; 20(12):2805-11. PubMed ID: 12065557
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial of placebo, droperidol or ondansetron to prevent nausea and vomiting after tonsillectomy in children receiving dexamethasone.
Flubacher P; Fournier N; Cherpillod J; Waridel F; Nydegger M; Albrecht E
Anaesthesia; 2017 Jul; 72(7):859-863. PubMed ID: 28449280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
